Background: Despite the enthusiasm for endovascular revascularization for chronic mesenteric ischemia (CMI), it is not clear if early benefits offset long-term patency rates. This systematic review aimed to provide an up-to-date comprehensive evidence synthesis evaluating the two approaches.
The treatment of chronic mesenteric ischemia (CMI) has evolved during the past few decades with the advances in diagnostic imaging and endovascular therapy. Mesenteric duplex ultrasound is currently an effective screening tool for visceral artery occlusive disease, 1 whereas computed tomography arteriography has emerged as the definitive diagnostic study and allows the assessment of the bowel and other intraabdominal contents in addition to a detailed evaluation of the vessels themselves. 2 Indeed, duplex ultrasound and computed tomography arteriography have largely replaced catheter-based arteriography as the diagnostic test for CMI. The advances in visceral imaging have been associated with a dramatic increase in the endovascular treatment of CMI, presumably because of earlier diagnosis, better understanding of the underlying disease process, and the less invasive nature of the endovascular approach. 3, 4 Zettervall et al 4 reported from the National Inpatient Sample and the Centers for Disease Control and Prevention database that the number of endovascular procedures performed for CMI has increased more than sevenfold (0.6-4.5/million; P < .01) from 2000 to 2012. The endovascular approach has largely supplanted the open surgical approach as the first-line treatment of CMI, similar to the endovascular approach to abdominal aortic aneurysms, because of its reported lower periprocedural morbidity and mortality rates. 3, 5, 6 However, the rate of recurrent symptoms and need for remediation appear to be higher for the endovascular approach, and the difference in longer term survival remains unclear. [6] [7] [8] Interestingly, Tallarita et al 9 have reported that survival after revascularization for CMI is predicted by the patient's comorbidities rather than by the type of procedure. Despite the widespread adoption of the endovascular approach, the quality of the supporting data is somewhat limited by evidence-based standards, and it is not clear that the early benefits of the 
METHODS
This systematic review was written in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement. 11 We followed an a priori protocol. This study used only aggregate deidentified data and was therefore exempt from Institutional Review Board review.
Search strategy. A comprehensive search of several databases from each database's inception to July 15, 2016 , in humans, in any language, was conducted. The databases included MEDLINE In-Process & Other NonIndexed Citations, MEDLINE, Embase, Cochrane Central Register of Controlled Trials, Cochrane Database of Systematic Reviews, and Scopus. The search strategy was designed and conducted by a medical reference librarian with input from the investigators. Controlled vocabulary supplemented with keywords was used to search for studies of revascularization for mesenteric ischemia. The actual strategy is available in the Appendix (online only).
Study selection process. We included all randomized controlled trials as well as observational studies meeting the following criteria: patients with a confirmed diagnosis of CMI by duplex ultrasound, computed tomography, or magnetic resonance imaging; patients who had undergone an endovascular revascularization intervention; compared with an open surgical intervention; and reported at least one of the outcomes of 30-day mortality, in-hospital complications, recurrence within 3 years after revascularization, or 3-year cumulative survival rate. We did not implement any other restrictions on language, study size, or publication type. Two independent reviewers screened all titles and abstracts of the identified studies for inclusion. Then a second phase of screening of the full-text articles was also done by independent pairs of reviewers.
Data extraction. Data were extracted independently by two reviewers into a standardized and web-piloted form and were later reconciled and cleaned. We collected data variables on study design and patient characteristics (age, sex, prevalence of cardiovascular risk factors, location and characteristics of lesions, and presenting symptoms). We also collected information on the interventions used as well as data on the outcomes of interest: 30-day mortality, in-hospital complications, recurrence within 3 years postoperatively, and 3-year cumulative survival.
Risk of bias assessment. The methodologic quality and risk of bias in the included studies were assessed by two independent reviewers. This was carried out using a modified version of the Newcastle-Ottawa Scale for observational studies 12 and the Cochrane tool for risk of bias assessment of randomized controlled trials. 13 Discrepancy between reviewers was resolved by consensus or by a third reviewer.
Statistical analysis. We calculated the event rate from each study arm. We then pooled the log-transformed event rates using the DerSimonian and Laird randomeffect models with the heterogeneity estimated from the Mantel-Haenszel model. All analyses were performed using the random-effect model to produce relative risks (RRs) and 95% confidence intervals (CIs). Heterogeneity was assessed using the I 2 statistic. This statistic represents the proportion of variability that is not attributable to chance. I 2 values >50% indicate substantial heterogeneity. Statistical analyses were conducted using OpenMeta[Analyst].
14 All values were two tailed, and a P < .05 was set as the threshold for statistical significance. [15] [16] [17] Data from noncomparative studies were used to provide incidence rate for outcomes of interest associated with the use of each intervention.
RESULTS

Characteristics of the included studies
The study selection process is depicted in Fig 1. After having identified 1644 potentially relevant references, we included 100 studies (18,726 patients with CMI; 10,679 had undergone endovascular revascularization, 8047 had undergone an open surgical revascularization). The mean age of the patients was 69 years (range, 9-99 years), and 28% of those were male. Patients in the included studies had a variable prevalence of several cardiovascular risk factors, as shown in the Table; 66% of them had a history of smoking, and 64% had hypertension. Most patients presented with abdominal pain (88%) and weight loss (74%). Detailed description of each study is available in Supplementary Table I (online only) .
Risk of bias evaluation of the included studies
All the available studies were nonrandomized (22 were comparative and 78 were noncomparative). Most of the 22 comparative studies showed low risk of bias in terms of selection of study participants, ascertainment of exposure, control for confounding, and ascertainment of outcome. Overall judgment of the risk of bias was mostly low risk. The methodologic quality of the 78 noncomparative studies was also adequate, as shown in Supplementary Figs 1 and 2 (online only). Supplementary Tables II and III (online only) also detail the risk of bias assessment of each included study.
Data synthesis of outcomes of interest
Thirty-day mortality. There was a nonsignificant increase in mortality at 30 days associated with using the open surgical intervention compared with the endovascular approach (18 studies; RR, 1.57; 95% CI, 0.84-2.93; Fig 2) .
In-hospital complications. Open surgery was associated with increased risk of in-hospital complications (15 studies; RR, 2.19; 95% CI, 1.84-2.60; Fig 3) . The most commonly reported complications were access site hematomas and embolization for the endovascular approach vs bowel resection and infections for the surgical approach.
Recurrence of CMI symptoms within 3 years of the intervention. Open surgery was associated with lower risk of 3-year recurrence (13 studies; RR, 0.47; 95% CI, 0.34-0.66; Fig 4) .
Three-year cumulative survival. There was no statistically significant difference in 3-year survival between the open surgical intervention and the endovascular approach (13 studies; RR, 0.96; 95% CI, 0.86-1.07; Fig 5) .
Noncomparative studies
Noncomparative studies provided incidence rates for each intervention for the outcomes of interest. These rates are summarized in Supplementary Fig 3 (online  only) . Supplementary Figs 4 to 11 (online only) show the forest plots of pooling the data across the singe-arm noncomparative studies.
Quality of evidence
The quality of evidence (certainty in the estimates) was low for the outcomes of in-hospital complications and symptom recurrence (because of the observational nature of included studies) and very low for 30-day mortality and 3-year mortality (because of the observational nature of included studies and imprecision). 
DISCUSSION
This systematic review and meta-analysis is the most rigorous and inclusive study documenting the perioperative and longer term outcomes for patients with CMI treated with either the open or endovascular approach. The search was performed using several electronic databases over the time frame from their inception to the present and was designed to identify all relevant articles, regardless of study design. Twenty-two comparative and 78 noncomparative studies were included in the metaanalyses encompassing almost 19,000 patients. The endovascular approach for CMI was found to be associated with lower perioperative complications and possibly mortality rates although not as durable as open revascularization, given the higher symptom recurrence rate at 3 years. Despite these differences in the perioperative outcomes and recurrence rates, the longer term survival at 3 years was comparable.
The overall findings are consistent with the generic advantages and disadvantages of the endovascular approach and are reminiscent of the early randomized trials comparing open and endovascular aneurysm repair. The lower perioperative morbidity and mortality rates clearly favor the endovascular approach, but this is at the expense of a higher recurrence or remediation rate. There was a fairly dramatic difference in perioperative mortality (8% vs 2%; RR, 1.57; 95% CI, 0.84-2.93), although this is not particularly surprising, given the magnitude of the open procedure and the population of CMI patients with their advanced age, multiple comorbidities, and debilitated condition. Indeed, it is somewhat surprising that the mortality rate for the open repair was so low, given the 9% to 13% mortality rates reported from the statewide and nationwide administrative databases, suggesting a publication bias for the open procedures included in the review. [3] [4] [5] The observed difference in the perioperative complications was likely even more dramatic in terms of the perceived difference from a patient's perspective, given the types of complications typically associated with the two approaches (eg, endovasculardaccess site; opendmyocardial infarction).
It is also likely that other "softer" perioperative end points, such as hospital length of stay, intensive care unit length of stay, discharge disposition, and transfusion requirement, may favor the endovascular approach. Such outcomes require further study. Notably, Zacharias et al 18 reported that both hospital and intensive care unit length of stay were lower for patients undergoing endovascular compared with open repair for CMI, whereas Indes et al 5 reported that a higher percentage of patients were discharged home (vs facility) after the endovascular approach. The comparable 3-year mortality rates observed in the current study suggest that the perioperative mortality benefit for the endovascular approach is negated by a higher mortality rate during the follow-up period, potentially because of the higher rate of recurrent symptoms. As noted before, Tallarita associated with a higher perioperative complication rate, higher 5-year primary patency (OR, 3.8; 95% CI, 2.4-5.8; P < .001), and higher 5-year freedom from recurrent symptoms (OR, 4.4; 95% CI, 2.8-7.0; P < .001) despite no difference in perioperative mortality or survival. Last, Pecoraro et al 21 (43 studies, 1795 patients) reported lower perioperative morbidity and mortality in the endovascular group despite a lower patency rate and no difference in survival. The reports from Gupta at al 20 and Pecoraro et al 21 compared the outcomes for both the open and endovascular approach before and after the year 2000 and did not find a difference in the outcomes between the two time intervals for either approach. Interestingly, the reports for the open procedures in the current study were older, and this was found to be a confounder in the analysis. This report is by far the most comprehensive and extensive report in the literature (100 studies, 18,820 patients). Any discrepancy between our findings (ie, perioperative mortality rate) and the other systematic reviews can likely be explained by the smaller sample sizes in the earlier reports.
The results seem to justify the "endovascular-first" approach to the treatment of CMI, given the lower perioperative complications and comparable long-term survival. Consistent with our findings, the American College of Radiology Appropriateness Criteria for CMI recommend angioplasty and stenting as the first-line treatment before open revascularization. 22 The available data appear to support the several-fold increase in the number of endovascular procedures used to treat CMI that has largely eclipsed the number of open procedures.
3-5,23 Inferences from this systematic review and metaanalysis must be interpreted with some caution, given the quality and design of the individual studies that composed the review. The majority were single-center retrospective reviews and thus subject to an inherent selection bias. This is reflected by the strength of the evidence that ranged from very low to low quality. It is unlikely that the patients undergoing open or endovascular repair were identical from an anatomic or comorbidity standpoint. The endovascular approach is generally favored for older, higher risk patients, some of whom may not be candidates for open repair. In contrast, the open approach is generally favored for younger, good-risk patients with lesions that are not amenable to endovascular treatment and those with failed endovascular procedures. Admittedly, a variety of creative endovascular approaches have been reported for lesions not traditionally considered endovascular candidates, 24, 25 and the longer term outcomes appear comparable for patients with visceral occlusions compared with those with stenoses. 26 Furthermore, the follow-up period is relatively brief, and thus it is not completely clear that the early benefits of the endovascular approach are sufficient to offset the higher recurrence rate despite the equivocal survival in our study. Notably, the recent clinical practice guidelines from the European Society for Vascular Surgery recommended that "the superior long term results of open surgery must be offset against a possible early benefit of endovascular intervention with regard to peri-procedural mortality and morbidity" for patients with CMI (recommendation 21, class 1, level of evidence B). 23 Accordingly, a patient-specific approach that incorporates age, comorbidities, anatomic lesion, risk of recurrence, compliance, and patient preference may be most appropriate.
At the present time, it is challenging to identify the optimal endovascular or open surgical approach because the comparison was simply between the "generic endovascular" and "generic open" approaches. The endovascular approach included both angioplasty alone and angioplasty in combination with intraluminal stenting. Furthermore, there was a variety of stent designs, including both covered and uncovered versions.
Similarly, the open surgical approach included antegrade aorto-celiac/aorto-superior mesenteric bypass, retrograde aorto/ilio-superior mesenteric artery bypass, and aortic endarterectomy. The outstanding relevant clinical questions, including the optimal number of vessels to visceral vessels to revascularize (ie, one, two, or three), the optimal stent (ie, covered vs uncovered), and the optimal bypass configuration (ie, antegrade vs retrograde), await further, more granular studies.
CONCLUSIONS
The endovascular approach to CMI is associated with better perioperative outcomes than in the open approach and comparable longer term survival. The evidence appears to support the current endovascular-first approach, although longer term outcome data from a randomized trial are still required. Open revascularization will likely continue to play a role for younger, healthier patients and those who are not endovascular candidates. 
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